v7.2: a larger RX roundup, with limits kept visible

All 964 v7.1 records remain: 957 are unchanged and seven received append-only additions. Twenty-three exact-product records bring the total to 987. The release adds 60 source cards: 30 primary-label summaries and 30 selected RX summaries, with 30 source-bound decision briefs.

Read the clinical roundup Directory of all 30 updates

Clinical output improvements

The new searchable roundup exposes renal action, evidence limitations and monitoring together. Source-specific quick-answer links avoid scrolling through unrelated evidence. Numeric antibiotic tables retain loading, maintenance, infusion duration, dialysis timing, population and renal-measure distinctions.

Pharmacokinetic-only findings remain labeled as PK, not converted into dosing schedules. New source findings distinguish malformed mirror text, uncertain indexing and differing instructions within a label. The current log contains 11 findings, including five added this release.

Source-integrity log | Clinical use guide

Preservation and implementation

Original source passages, evidence boxes, methods, aliases, comparisons and historical research snapshots remain intact. Native PHP lookup, product-confirmation safeguards, repaired pagination, Adverge placements and the counter implementation are retained. The separate historical drug database was not imported.

Coverage is still incomplete

749 of 4,442 recorded RX URLs now have selected content (16.86%). This is not a clinical-protocol completion percentage. All 26 A-Z letters remain open for complete linked-monograph review. Counts, 26-letter status and workload estimate.

Attempt outcomes, including failures

Verification limits

Selected sections were checked, not full product monographs or every current revision. EXBLIFEP uses an identified 2024 FDA approval label with a visible currency hold. Existing brand-currency, source and formulation questions remain open unless explicitly resolved. The source/recovery release report contains local software-test results separately from clinical checks.

No live deployment or independent clinical sign-off is claimed. Production ad fill, consent/CSP behavior, real counter values and hosted operation require post-deployment verification. A label mirror is not a second independent clinical source.